Methyl 2-bromo-4-chloronicotinate

Catalog No. :
ACREJQ569
CAS No. :
1804384-19-7
Molecular Formula :
C7H5BrClNO2
Molecular Weight :
250.48

IUPAC Name:methyl 2-bromo-4-chloronicotinate

Methyl 2-bromo-4-chloronicotinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$98.00Login to see priceIn stockInquiry
5g97%$342.00Login to see priceIn stockIn stock
10g97%$561.00Login to see priceIn stockIn stock
25g97%$1326.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-bromo-4-chloronicotinate
IUPAC Namemethyl 2-bromo-4-chloronicotinate
MDL No.MFCD28734551
Molecular FormulaC7H5BrClNO2
Molecular Weight250.48
SMILESO=C(OC)C1=C(Br)N=CC=C1Cl
InChI KeyXVSQDHCCSZHVKB-UHFFFAOYSA-N
Synonymmethyl 2-bromo-4-chloronicotinate;2-bromo-4-chloronicotinate methyl ester;3-Pyridinecarboxylic acid, 2-bromo-4-chloro-, methyl ester;3-Pyridinecarboxylic acid, 2-bromo-4-chloro-, methyl estermethyl 2-bromo-4-chloropyridine-3-carboxylate
CAS No.1804384-19-7
PubChem CID87513187

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312-P330

Synthetic Route by SureRoute

1. ACREJQ569 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACREJQ569 route product structure diagram
    ACREJQ5691804384-19-7 In Stock
Inquiry

2. ACREJQ569 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACHYRB501 route compound structure diagram
    ACHYRB5011256833-88-1 In Stock
  4. Then
  5. ACREJQ569 route product structure diagram
    ACREJQ5691804384-19-7 In Stock
Inquiry

Comments (0)